Yekaterina Chudnovsky insider trades: Elicio Therapeutics (ELTX) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Yekaterina reports to the SEC
Open-market buys and sales
1 trade reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Dec 22, 2023 | ELTX | ↑ Buy | 1,213,000 | $5.81 | $7.0M | Held by GKCC, LLC | Dec 26, 2023 (4d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Yekaterina Chudnovsky's insider trades
Yekaterina Chudnovsky is a director at Elicio Therapeutics (ELTX). Since Dec 22, 2023, Yekaterina has reported 1 open-market purchase worth $7.0M and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (9 filings), other transactions (3 filings), conversions (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ELTX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.